09-27-2018 03:47 PM CET - Health & Medicine
Print

Injectable Drug Delivery Market 2018-2025 With Global Application Analysis, Substitute Study and Dominating Players Like Baxter International Inc., BD, Gerresheimer, Pfizer, SCHOTT, Alkermes, Eli Lilly and Company, Sandoz, Terumo Medical Corporation

Press release from: Data Bridge Market Research
Injectable Drug Delivery Market
Injectable Drug Delivery Market


Databridgemarketresearch.com adds “Injectable Drug Delivery Market 2018-2025 With Global Application Analysis, Substitute Study and Dominating Players Like Baxter International Inc., BD, Gerresheimer, Pfizer, SCHOTT, Alkermes, Eli Lilly and Company, Sandoz, Terumo Medical Corporation” reports to its database.

This report provides in depth study of “Injectable Drug Delivery Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Injectable Drug Delivery Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

This report focuses on the Injectable Drug Delivery Market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Global Injectable Drug Delivery Market development in North America, Europe, Asia-Pacific, South America, Middle East and Africa.

Download PDF Sample Copy of Report @ databridgemarketresearch.com/request-a-sample/?dbmr=globa...

Some of the major players operating in global injectable drug delivery market are -

BD, Gerresheimer AG, Pfizer, Inc., Schott AG, Alkermes Plc., Eli Lilly and Company, Sandoz, Terumo Corporation, Teva Pharmaceuticals Industries Ltd., Ypsomed, Bespak, Baxter International, Inc., Nova Nordisk A/S, Sanofi, Crossject, InjexPharma GmbH, Elcam Medical, Unilife Corporation, West Pharmaceutical Services, Inc. and Vetter Pharma-Fertigung GmbH & Co. KG. among others.

Market Segmentation: Global Injectable Drug Delivery Market

By Type

• Injectable Drug Delivery Devices
• Injectable Drug Delivery Formulation
• Novel Drug Delivery Formulations

By Application

• Hormonal Disorders
• Oncology
• Autoimmune Diseases
• Orphan Disease
• Other Applications

By Usage Pattern

• Curative Care
• Immunizations
• Others

By Mode Of Administration

• Skin, Circulatory/ Muskoskeletal
• Organs
• Central Nervous System

By End User

• Hospitals And Clinics
Home Healthcare Settings
Research Laboratories
• Pharmaceutical and Biotechnological Companies
• Others

By Distribution Channel

• Hospital Pharmacy
• Pharmacy Stores
• Direct Tender
• Online Pharmacy

By Geography

• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

To Avail 10% Discount On This Report Mail Us on: - sopan.gedam@databridgemarketresearch.com

Market Analysis: Global Injectable Drug Delivery Market

Global Injectable Drug Delivery Market is expected to reach USD 1,104,096.5 Million by 2025 from USD 378,998.2 Million in 2017, at a CAGR of 12.4% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

The major factors contributing to the growth of the market includes factors such rising cases of chronic diseases and due to rising demand of self-injection devices. On the other hand needle stick injuries and infections may hinder the growth of the market.

Table of Contents:

1. INTRODUCTION

1.1. OVERVIEW OF GLOBAL INJECTABLE DRUG DELIVERY MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED

2. MARKET SEGMENTATION

2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS

3. MARKET OVERVIEW

3.1. DRIVERS

3.2. RESTRAINTS

3.4. CHALLENGES

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. GLOBAL INJECTABLE DRUG DELIVERY MARKET, REGULATORY

6.1. OVERVIEW

6.2. U.S. FDA APPROVAL
6.3. CE MARKING (EUROPEAN CONFORMITY)
6.4. EM (EUROPEAN MEDICINE AGENCY)

7. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY TYPE

7.1. OVERVIEW

7.2. INJECTABLE DRUG DELIVERY DEVICES

7.3. INJECTABLE DRUG DELIVERY FORMULATION

8. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION

8.1. OVERVIEW
8.2. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION
8.3. HORMONAL DISORDERS

8.4. ONCOLOGY
8.5. AUTOIMMUNE DISEASES

8.6. ORPHAN DISEASE
8.7. OTHER APPLICATIONS

9. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN

9.1. OVERVIEW
9.2. CURATIVE CARE
9.3. IMMUNIZATIONS
9.4. OTHER USAGE PATTERN

10. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION

10.1. OVERVIEW
10.2. SKIN
10.3. CIRCULATORY/ MUSKOSKELETAL
10.4. ORGANS
10.5. CENTRAL NERVOUS SYSTEM

11. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY END USER

11.1. OVERVIEW
11.2. HOSPITALS AND CLINICS
11.3. HOME HEALTHCARE SETTINGS
11.4. RESEARCH LABORATORIES
11.5. PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES
11.6. OTHER END USERS

12. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL

12.1. OVERVIEW

13. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY GEOGRAPHY

13.1. OVERVIEW
13.2. NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET

13.3. EUROPE INJECTABLE DRUG DELIVERY MARKET

13.4. APAC INJECTABLE DRUG DELIVERY MARKET

13.5. SOUTH AMERICA INJECTABLE DRUG DELIVERY MARKET

13.6. MEA INJECTABLE DRUG DELIVERY MARKET

14. GLOBAL INJECTABLE DRUG DELIVERY MARKET, COMPANY SHARE

14.1. COMPANY SHARE ANALYSIS: GLOBAL

15. COMPANY PROFILES

15.1. BECTON, DICKINSON AND COMPANY

15.2. PFIZER

15.3. BAXTER INTERNATIONAL

15.4. GERRESHEIMER AG

15.6. ALKERMES INC.

15.7. ANTARES PHARMA

15.8. BESPAK (SUBSIDIARY OF CONSORT MEDICAL COMPANY)

15.9. ELCAM MEDICAL

15.10. ELI LILLY AND COMPANY

15.11. HASELMEIER

15.12. MYLAN N.V.

15.13. NOVO NORDISK

15.14. OWEN MUMFORD LTD

15.15. SANDOZ INTERNATIONAL GMBH

15.16. SANOFI

15.17. TERUMO CORPORATION

15.18. TEVA PHARMACEUTICAL

15.19. WEST PHARMACEUTICAL SERVICES, INC

15.20. YPSOMED HOLDING AG

16. RELATED REPORTS

Order a Copy of Global Injectable Drug Delivery Market Report @ databridgemarketresearch.com/inquire-before-buying/?dbmr=...

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.
News-ID: 1267739 • Views: 332
More releasesMore releases

You can edit or delete your press release here: